[Drug-induced myopathies].
Ando
Hitoshi
H
Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science.
Fujimura
Akio
A
D002995:Clofibric Acid / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D002995:Clofibric Acid